Next Article in Journal
Deficiency in Androgen Receptor Aggravates Traumatic Brain Injury-Induced Pathophysiology and Motor Deficits in Mice
Next Article in Special Issue
HPLC-DAD-qTOF Compositional Analysis of the Phenolic Compounds Present in Crude Tomato Protein Extracts Derived from Food Processing
Previous Article in Journal
Progress in the Medicinal Value, Bioactive Compounds, and Pharmacological Activities of Gynostemma pentaphyllum
Previous Article in Special Issue
Six Common Herbs with Distinctive Bioactive, Antioxidant Components. A Review of Their Separation Techniques
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 26
Issue 20
10.3390/molecules26206251
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Profile, Free Radical Scavenging and Anti-Inflammatory Properties of Acalypha Indica Root Extract: Evidence from In Vitro and In Vivo Studies

by
Ravi Sahukari
1,
Jyothi Punabaka
1,
Shanmugam Bhasha
1,
Venkata Subbaiah Ganjikunta
1,
Shanmugam Kondeti Ramudu
2,
Sathyavelu Reddy Kesireddy
1,
Weibing Ye
3,* and
Mallikarjuna Korivi
3,*
1
Department of Zoology, Sri Venkateswara University, Tirupati 517502, India
2
Department of Zoology, PRR &VS Government Degree College, Vidavalur 524318, India
3
Exercise and Metabolism Research Center, College of Physical Education and Health Sciences, Zhejiang Normal University, Jinhua 321004, China
*
Authors to whom correspondence should be addressed.
Molecules 2021, 26(20), 6251; https://doi.org/10.3390/molecules26206251
Submission received: 8 September 2021 / Revised: 7 October 2021 / Accepted: 11 October 2021 / Published: 15 October 2021
(This article belongs to the Special Issue Antioxidants from Natural Sources: Separation and Characterization)
Browse Figures
Review Reports Versions Notes

Abstract

:
In our in vitro and in vivo studies, we used Acalypha indica root methanolic extract (AIRME), and investigated their free radical scavenging/antioxidant and anti-inflammatory properties. Primarily, phytochemical analysis showed rich content of phenols (70.92 mg of gallic acid/g) and flavonoids (16.01 mg of rutin/g) in AIRME. We then performed HR-LC-MS and GC-MS analyses, and identified 101 and 14 phytochemical compounds, respectively. Among them, ramipril glucuronide (1.563%), antimycin A (1.324%), swietenine (1.134%), quinone (1.152%), oxprenolol (1.118%), choline (0.847%), bumetanide (0.847%) and fenofibrate (0.711%) are the predominant phytomolecules. Evidence from in vitro studies revealed that AIRME scavenges DPPH and hydroxyl radicals in a concentration dependent manner (10–50 μg/mL). Similarly, hydrogen peroxide and lipid peroxidation were also remarkably inhibited by AIRME as concentration increases (20–100 μg/mL). In vitro antioxidant activity of AIRME was comparable to ascorbic acid treatment. For in vivo studies, carrageenan (1%, sub-plantar) was injected to rats to induce localized inflammation. Acute inflammation was represented by paw-edema, and significantly elevated (p < 0.05) WBC, platelets and C-reactive protein (CRP). However, AIRME pretreatment (150/300 mg/kg bodyweight) significantly (p < 0.05) decreased edema volume. This was accompanied by a significant (p < 0.05) reduction of WBC, platelets and CRP with both doses of AIRME. The decreased activities of superoxide dismutase, catalase, glutathione reductase and glutathione peroxidase in paw tissue were restored (p < 0.05 / p < 0.01) with AIRME in a dose-dependent manner. Furthermore, AIRME attenuated carrageenan-induced neutrophil infiltrations and vascular dilation in paw tissue. For the first time, our findings demonstrated the potent antioxidant and anti-inflammatory properties of AIRME, which could be considered to develop novel anti-inflammatory drugs.

1. Introduction

Inflammation is a complex biological immune response to harmful stimuli of irritant chemicals, pathogens and damaged local injury cells in the tissue. Inflammatory system plays an important role in life-threatening diseases including COVID-19, cancer, diabetes and cardiovascular dysfunction [1,2]. Leukocyte activation such as macrophages, neutrophils, eosinophils and monocytes may occur during inflammation in order to protect the tissue, and simultaneously trigger the production of reactive oxygen species (ROS) or free radicals [3]. These ROS, include superoxide anion (O2−), hydrogen peroxide (H2O2), and hydroxyl radical (•OH) are highly reactive in nature, which counteract with adjacent polyunsaturated fatty acids, proteins and DNA, and leading to cause lipid peroxidation, protein degradation, and DNA damage, respectively [4,5]. In order to combat this oxidative stress, cells are equipped with endogenous antioxidant enzymes and non-enzymatic defense systems. The antioxidant enzymes, mainly superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR) and glutathione peroxidase (GPx) however reach insufficient during inflammation and/or oxidative stress [4,6]. C-reactive protein is an acute phase inflammatory marker that remarkably elevates in various inflammatory diseases, including COVID-19, cancer, cardiovascular diseases (CVDs) and diabetes [7,8]. Oxidative stress can trigger various genes involved in inflammatory pathways, including nuclear factor kappa B (NF-κB), and intrinsically involved in the progression of chronic diseases [2,4]. It is therefore necessary to supplement anti-inflammatory and/or antioxidant compounds to assist the impaired immune and antioxidant defense systems.
Various plant-derived or synthetic antioxidant and anti-inflammatory compounds have been used to treat oxidative insult and inflammation, as these substances are capable in scavenging of ROS and inflammatory mediators [9,10]. However, the synthetic compounds have been claimed to cause mild to severe adverse effects. On the other hand, usage of herbal medication has been increased over the past three decades, and ~80% of the world’s population living in the developing nations are rely on plant-based medicinal products as the primary source of healthcare [11]. Although several herbal compounds have been widely used as antioxidant or anti-inflammatory substances, many of them are yet to be investigated and their molecular mechanism needs to be disclosed. Therefore, identification of novel and effective therapeutic substances from medicinal plants with low or no side effects became prioritized research. The phenolic compounds and flavonoids are a family of bioactive constituents have been demonstrated as promising source for new medications to treat inflammation and related chronic painful diseases [12]. Phytol, a diterpene constituent of chlorophyll has been shown to suppress pro-inflammatory cytokines release through downregulation of NF-κB signalling pathway [13]. Methanolic extracts Sideritis bilgeriana reported to suppress tumour necrosis factor alpha (TNF-α), interleukin-1β (IL-1β) and leukocyte migration in carrageenan-induced pleurisy model. These pharmacological effects are due to the presence of phenolic and flavonoids content detected by HPLC-DAD-UV analysis [14].
Acalypha indica also known as ‘Indian copperleaf’ or ‘Indian mercury’ is a medicinal plant that belongs to Euphorbiaceae family. A. indica is widely distributed throughout the Asia and Africa. In folk medicine, the whole plant and leaves of A. indica have been used to treat asthma, pneumonia, stomach discomforts, skin injuries and snake bites [15,16]. Leaves of A. indica have been scientifically tested for their anti-bacterial [17], anti-inflammatory [18] and antioxidant [19] properties. Few studies isolated and identified the phytochemical constituents from the leaf extracts of A. indica [16,19]. Stems of A. indica are also reported to have antioxidant, glucose lowering and hepato-protective properties in experimental diabetic rats [20].
Nevertheless, the pharmacological properties of A. indica root methanolic extract (AIRME) have not been demonstrated. Furthermore, isolation and characterization of phytochemical compounds in AIRME is yet to be performed. We assume that roots of A. indica may also contain various phytochemical constituents that could exhibits pharmacological efficacies. Therefore, we aimed to perform HR-LC-MS and GC-MS techniques to identify the bioactive compounds in AIRME. In vitro studies were performed to investigate the free radical scavenging activity of AIRME. Subsequently, in vivo studies were conducted on rats to evaluate the antioxidant and anti-inflammatory activities of AIRME in carrageenan-induced acute inflammatory model.

2. Results

2.1. Phytochemicals in A. indica Root Extract

Qualitative estimation of phytochemicals based on color intensity in the AIRME revealed that it has several phytochemical compounds such as phenols, flavonoids, saponins, tannins, reducing sugars, alkaloids, terpenoids, coumarins, anthraquinones and anthocyanins. We then quantified major phytochemicals, phenols and flavonoids based on qualitative analysis, which aided in further fractionation, isolation and biological assessment. Quantitative estimations revealed total phenolic content in AIRME was 70.92 mg of gallic acid equivalent/g extract, and flavonoids content was 16.01 mg of rutin/g extract.

2.2. Phytochemical Profile of A. indica Root Methanolic Extract

After quantification of phytochemicals, the AIRME was subjected to GC-MS and HR-LC-MS for profiling their individual chemical constituents. GC-MS analysis revealed that the extract contains a significant amount of lipid soluble constituents (volatile) and their metabolites. To be specific, GC-MS results showed 14 volatile compounds whereas HR-LC-MS explored 101 semi volatile and non-volatile phytochemicals in AIRME. The details of each phytochemical constituent, including molecular formula, mass, PubChem CID and percentage were presented in Table 1. The predominant phytomolecules in AIRME through HR-LC-MS were, retusoquinone (1.694%), ramipril glucuronide (1.563%), antimycin A (1.324%), propionylglycine methyl ester (1.18%), swietenine (1.134%), quinone (1.152%), oxprenolol (1.118%), choline (0.847%), bumetanide (0.847%) and fenofibrate (0.711%). Similarly, the major phytochemical constituents by GC-MS were piperidine-2,5-dione (3.73%), cephalotaxine, 3-deoxy-3,11-epoxy-,(3a,11a)- (2.66%) and octadecanoic acid (2.053%). Most of these compounds displayed a higher number of hydrogen bond donor/acceptor counts. The chromatograms obtained from GC-MS and HR-LC-MS analyses (Supplementary Materials Figures S1 and S2) and chemical structures of all compounds identified in AIRME (Figures S3 and S4) were provided as Supplementary Materials.
Computational calculations for the adverse effect descriptors of AIRME compounds showed that many compounds may not possess mutagenicity, tumorigenicity, reproductive toxicity and irritation (Table 1). These predictive non-toxic effects of the compounds need to be further confirmed through laboratory studies.

2.3. A. indica Root Extract Scavenges DPPH and Hydroxyl Radicals

In vitro free radical scavenging activity of AIRME was determined by measuring the inhibition of DPPH and •OH. The results revealed that AIRME (10–50 µg/mL) significantly scavenges the DPPH radical in a concentration dependent manner with a IC50 of 15.85 µg/mL, whereas the IC50 with ascorbic acid treatment was 5.71 µg/mL (Table 2). Hydroxyl radical-induced deoxyribose sugar damage was significantly decreased by AIRME in a concentration-dependent manner with IC50 of 14.74 µg/mL (Table 2). These findings signify the potent free radical scavenging activity of AIRME.

2.4. A. indica Root Extract Suppress Hydrogen Peroxide and Lipid Peroxidation In Vitro

We found that the AIRME (20–100 µg/mL) effectively converted the hydrogen peroxide into water with IC50 value of 65.40 µg/mL whereas ascorbic acid converted at IC50 of 33.31 µg/mL. Furthermore, anti-lipid peroxidation activity of AIRME (20–100 µg/mL) was evidenced by a substantial suppression of lipid peroxides in egg homogenate. Inhibition of lipid peroxidation was proportionate with AIRME concentrations, and IC50 was 79.70 µg/mL. The efficacy of AIRME against hydrogen peroxide and lipid peroxidation propagation was comparable to the potency of ascorbic acid (Table 2).

2.5. A. indica Root Extract Decreases Paw Edema Volume in Rats

Carrageenan induced acute inflammation was evidenced by the appearance of paw edema in rats. Carrageenan-induced rat paw edema is a well-established animal model to evaluate the anti-inflammatory properly of phytochemicals [10,21]. The edema volume was sharply increased 1 h after injection (38%) and reached maximum size by 5/6 h (52%) (Figure 1). However, edema volume was significantly decreased with ARIME (150 and 300 mg/kg b.w.) pretreatment. Although both doses of AIRME significantly inhibited the edema growth against carrageenan, the high-dose of AIRME (300 mg/kg b.w.) is more effective in inhibiting (p < 0.05) the edema development. The edema volume with AIRME high-dose at 1, 2, 3, 4, 5 and 6 h after injection was 24, 32, 34, 29, 21 and 7%, respectively, which is significantly lower compared to carrageenan group at all time points (Figure 1). Our results further emphasized that the decreased edema volume with AIRME was parallel with the standard anti-inflammatory drug, diclofenac treatment. Physical observations of paw further revealed that carrageenan-induced inflammatory edema was smaller in AIRME pretreated rats than that of their disease controls (Figure 2).

2.6. A. indica Root Extract Attenuates Acute Inflammatory Response in Rats

Hematological analyses showed a significant rise in white blood cells and platelets in carrageenan injected group compared with normal control (p < 0.05), which indicates acute inflammation in rats. The surge in WBC count and platelets in inflammatory rats was not seen in AIRME pretreated rats. This was represented by a remarkably less number of WBC and platelets with low-dose (150 mg/kg; p < 0.05) and high-dose (300 mg/kg; p < 0.01) of AIRME treatment (Table 3). Similarly, elevated CRP level (55.94 ± 4.86 ng/mL) with carrageenan injection was substantially decreased in AIRME treated groups (low-dose 36.98 ± 3.24; high-dose 31.84 ± 3.09 ng/mL). The dose-dependent decrease of CRP with AIRME was statistically significant (p < 0.05 and p < 0.01) compared with disease control group (Table 3).

2.7. A. indica Root Extract Restores Antioxidant Enzyme Activities in Paw Tissue

We then studied the response of antioxidant system with AIRME treatment against acute inflammation. Carrageenan-induced impaired antioxidant homeostasis in paw tissue was represented by a significant reduction (p < 0.05) of SOD, CAT, GR and GPx enzyme activities. It is worth to note that carrageenan-induced loss of antioxidant enzyme activities was not seen in AIRME pretreated groups (150 and 300 mg/kg body weight). The dose-dependent preservation of antioxidant enzyme activities with AIRME was significant compared to the disease control group. To be specific, antioxidant property of the high-dose of AIRME is more effective (p < 0.01) and almost similar to the standard anti-inflammatory drug, diclofenac (Figure 3).

2.8. A. indica Root Extract Prevent Tissue Architectural Damage

Tissue architectural derangements that occurred upon carrageenan injection, and tissue protective effects with AIRME pretreatment against inflammatory damage were examined through histopathological studies. Images from normal control and AIRME control groups showed normal architecture of the paw tissue with normal muscle around decalcified bone (DB) without vascular dilation and neutrophil infiltration. Carrageenan-induced acute inflammation was visualized by redness and swelling of paw, and tissue derangements were represented by edema, vascular dilation and accumulation of neutrophil infiltration in disease control group (Figure 4). Nevertheless, AIRME pretreatment (150 and 300 mg/kg b.w.) confined the paw tissue architectural damage through preventing the neutrophil infiltration, vascular dilation and suppressing edema (Figure 4). The anti-edematous activity of AIRME against acute localized inflammation was comparable with diclofenac treatment.

3. Discussion

Previous studies have shown the antioxidant, anti-inflammatory and tissue protective properties of A. indica leaf and stem extracts [18,19,20], but not the root extract. Besides, no study has identified the phytochemical constituents in A. indica root methanolic extract (AIRME) yet. For the first time, we screened the phytochemical constituents in AIRME, and reported 101 and 14 compounds from HR-LC-MS and GC-MS techniques, respectively. The major phytomolecules in AIRME were ramipril glucuronide (1.563%), antimycin A (1.324%), swietenine (1.134%), quinone (1.152%), oxprenolol (1.118%) choline (0.847%), bumetanide (0.847%) and fenofibrate (0.711%). Then, we demonstrated the antioxidant and anti-inflammatory properties of AIRME through in vitro and in vivo studies. In vitro free radical scavenging activity of AIRME was evidenced by a potent inhibition of DPPH and •OH radicals and substantial suppression of H2O2 and lipid peroxidation. Evidence from in vivo studies revealed that carrageenan-induced paw edema was significantly decreased (volume) in AIRME pretreated rats. The surge in WBC and platelets with response to acute inflammation was significantly suppressed in AIRME pretreated groups. Furthermore, elevated CRP levels with carrageenan injection were not seen in AIRME pretreated rats, which indicates potent anti-inflammatory activity of AIRME. Most importantly carrageenan-induced impaired antioxidant homeostasis in paw tissue was attenuated with AIRME treatment. This was represented by a significant conservation of SOD, CAT, GPx and GR activities against carrageenan-induced loss. Histopathological studies further emphasize the tissue protective effect of AIRME against carrageen-induced tissue derangements, accumulation of neutrophil infiltration and vascular dilation.
Oxidative stress is an imbalance between pro-oxidants and antioxidants that is typically involved in the progression of many diseases, including cancer, CVDs, diabetes and atherosclerosis [22]. Natural antioxidant compounds, such as plant-based phenols and flavonoids can give protection against oxidative stress by scavenging the highly reactive free radicals, and inhibiting the lipid peroxidation [23]. In this study, naturally occurred large quantities of phenols (70.92 mg of gallic acid/g) and flavonoids (16.01 mg of rutin/g) in AIRME could potentially scavenge the free radicals, and thereby prevent the oxidative stress. HR-LC-MS is a chromatography technique that examines the polar (phenols and flavonoids) and semi-polar compounds in plant extract [19]. Furthermore, GC-MS analysis reported 14 compounds wherein non-polar/volatile phytochemicals are found in the root extract. Hydroxyl groups play an important role as a donor of hydrogen bonds, which is necessary for free radical scavenging, reduction of metals and molecular interaction with biomolecules [24]. In this study, we counted the hydrogen bond donors for all the identified phytochemicals through HR-LC-MS and GC-MS. The results showed that the majority of the compounds identified by HR-LC-MS exhibited these groups; while the number of compounds identified by GC-MS was lower (Table 1). These findings revealed that AIRME is a good source of antioxidant compounds, which could effectively eradicate the free radicals and/or prevent the oxidative stress.
Free radicals, and free radical source H2O2, is a well-known weak oxidizing agent, rapidly cross the cell membrane, reacts with ions such as Fe2+/Cu2+ and resulting in the generation of highly toxic hydroxyl radicals [25]. The cellular antioxidant defense system plays a significant role in quenching the toxic free radicals, and thereby protects the biomolecules from oxidative modification. In addition to the cellular antioxidant mechanism, the exogenous antioxidants from natural medicinal plants can enhance the protection against disease or stress [26,27]. The free radical scavenging activity of AIRME in this study was revealed by efficient scavenging of H2O2, •OH and DPPH radicals, which is comparable to the scavenging ability of the standard ascorbic acid (Table 2). The existence of phenols and flavonoids with HBDC, such as Bumetanide, Bussein’s hydrolysis product, Coproporphyrin II, Dihydrodeoxystreptomycin, Ramipril glucuronide and Trandolapril glucuronide further strengthen the free radical scavenging or antioxidant activity of AIRME.
Identification and developing of natural medicinal compounds without adverse effects is critical for pharmaceutical companies in order to promote the medicinal values and to gain final marketing approval. Toxicity evaluation of the plant compounds is typically a laborious process with several complexities, and includes the requirement of animal models, cell lines, expenditure, man power and a long duration of time. To overcome these difficulties, computational calculation is an alternative approach to assess the adverse effects of newly identified plant compounds [28]. Therefore, we used computational calculation, and measured the potential adverse effects, such as mutagenicity, tumorigenicity, irritant and reproductive toxicity of the compounds that were identified in AIRME. The predictions showed that most of the compounds in AIRME may not have mutagenicity, tumorigenicity, irritant and reproductive toxicity. These toxicity assessments are predictive, and laboratory studies are necessary to confirm the toxicity of individual phytomolecules of AIRME.
Acute inflammatory response is mainly represented by an increased vascular permeability and neutrophil infiltration, which leads to edema formation. In the cellular events, extravasation of fluids and proteins is accompanied with excessive accumulation of leukocytes at the inflammatory site [29,30]. Carrageenan, a highly sulfated polysaccharide is widely used as food additive due to its capability to enhance the food structure [31]. Carrageenan (non-antigenic phlogistic agent)-induced rat paw edema is a well-established and widely used model to evaluate the anti-inflammatory properly of plant and synthetic compounds [10,21]. Carrageenan-induced edema development is a biphasic acute inflammatory response [29]. In the first phase from 0 to 2.5 h, carrageenan triggers the release of acute phase mediators, mainly serotonin, histamine and kinins, which influence the vascular permeability [32]. Then, prostaglandins are the key players in the second phase of inflammation that occurs around 3 h after carrageenan injection [33]. These events provoke the release of several pro-inflammatory mediators, where inhibition terminates the inflammatory process [34]. Local inflammation is associated with oxidative burst and increased production of pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6 and nitric oxide [35].
The carrageenan-induced inflammation in our study was witnessed by increased CRP levels and elevated WBC and platelet count. Platelets usually gathered at the injured site, adhere to the WBCs and release cytokines and chemokines that are chemotactic for neutrophils and monocytes. These events subsequently increase inflammation [36]. CRP is an acute phase inflammatory marker that increases rapidly and dramatically in response to acute inflammation [37]. It has been shown that CRP can enhance the platelet-activating factor (PAF)-induced inflammation via binding to PAF and its precursor [38]. One of our key findings is that AIRME received rats exhibited lower levels of CRP as well as decreased WBC and platelet count, which implies potent anti-inflammatory activity. In the phytochemical screening, we reported several pharmacological compounds, like oxtriphylline (0.677%), choline (0.847%), bumetanide (0.847%), swietenine (1.13%) and fenofibrate (0.711%) in the root extract. A previous study has shown that choline and aspirin together can suppress the pro-inflammatory mediators against acute inflammation induced by carrageenan and lipopolysaccharide [39]. Other phytochemicals, bumetanide [40], fenofibrate [41] and swietenine [42] are also reported to possess anti-inflammatory activity via downregulation of pro-inflammatory cytokines. Another study documented that methanolic extract Sideritis bilgeriana suppressed TNF-α, IL-1β and leukocyte migration in carrageenan-induced pleurisy model, which is due to the presence of f phenolic and flavonoids content [14]. It is persuaded that existence of these pharmacological compounds in AIRME could act as anti-inflammatory agents, and thereby suppress inflammation and edema in carrageenan-injected rats. The anti-inflammatory property of AIRME was comparable to the diclofenac, a nonselective non-steroidal anti-inflammatory drug.
ROS or free radicals at low concentrations act as signaling molecules; however, they are deleterious to cells at high concentrations. Due to their highly reactive nature, ROS reacts with vital biomolecules, proteins, lipids and DNA and can cause irreversible damage. To prevent such oxidative damage, cells have evolved an array of defense systems, including antioxidant enzymes that scavenge excessive ROS. Cells experienced oxidative stress when the balance tipped between antioxidants and free radicals [4,5]. All antioxidant enzymes, including SOD, CAT, GPx and GR estimated in paw edema were significantly decreased after carrageenan injection, which reflects impaired antioxidant homeostasis and state of oxidative stress. Carrageenan injection has been reported to trigger intracellular ROS production, decrease antioxidant capacity and cause inflammation [31,43]. Excessive production of oxygen free radicals in the extracellular space and relatively low activities of SOD and CAT in the inflammatory state increase the vulnerability of extracellular components to ROS and stimulate chemotaxis for other inflammatory cells [44].
However, pretreatment of AIRME restored the SOD, CAT, GPx and GR activities against carrageenan-induced loss. In vivo antioxidant property of AIRME is corroborates with in vitro DPPH radical scavenging activity, and suppressed H2O2 and lipid peroxidation. Similar to our findings, oral administration of amiodarone, an anti-arrhythmic agent to carrageenan-injected rats has been shown to decrease the paw edema volume and inflammation in association with increased antioxidant enzyme activities [45]. The anti-inflammatory property of Pistacia lentiscus fruit oil is accompanied by the increased activities of SOD, CAT and GPx and decreased lipid peroxidation in rat paw tissue after carrageenan injection [46]. Another study showed that cashew nuts supplementation ameliorated the carrageenan-induced diminution of SOD and CAT activities and GSH concentrations. Cashew nuts further suppressed the release of pro-inflammatory cytokines and prevent the oxidative stress [47]. These findings imply that the anti-inflammatory property of natural compounds is associated with antioxidant property against carrageenan-induced oxidative stress. The increased antioxidant enzyme activity or free radical scavenging capacity of AIRME in our study might be due to the presence of various phytochemicals in the root extract. AIRME phytochemical screening represented with high HBDC and HBAC, including ramipril glucuronide (1.563%), antimycin A (1.324%), dihydrodeoxystreptomycin (1.021%), swietenine (1.134%), hydrolysis product of bussein (1.145%), terbinafine metabolite (1.098), oxprenolol (1.118%) and 3-O-methylrimiterol (1.118%).
The antioxidant activity of AIRME was further confirmed by tissue protective effect against carrageenan-induced architectural damage to paw tissue. From the histopathological studies, it is visible that the inflamed area appears with edema, congestion, vascular dilation and neutrophil infiltration. These morphological changes in paw tissue are the typical events of local inflammation caused by carrageenan injection. However, AIRME treatment prior to carrageenan injection decreased edema and prevented vascular dilation and a surge in neutrophil infiltration, which reveals an anti-inflammatory property. Suppressed paw edema and neutrophil recruitment in paw tissue have been reported as a key anti-inflammatory property of crocin (an active constituent of saffron) against histamine injection in rats [48]. Naik and colleagues reported that pathological changes, including hepatic steatosis with severe swelling of hepatocytes and fat accumulation in obese rats were partially attenuated with A. indica leaf extracts. However, this study not revealed the phytochemical composition in the leaf extracts of A. indica [49]. Another study showed that quinone alkaloid pretreatment significantly inhibited carrageenan-induced paw edema in rats [50]. Astragalin, a naturally existing flavonoid in plants alleviated epithelial hyperplasia, severe leukocyte infiltration and sub epidermal edema induced by carrageenan injection [51]. AIRME also possesses flavonoids, quinine, phenols and other active ingredients which may contribute for the tissue protective effects. To our knowledge, this is the first evidence to demonstrate the tissue protective effect of AIRME against carrageenan-induced tissue damage.

4. Materials and Methods

4.1. Chemicals

The chemicals used in this research were obtained from the following scientific companies: Sigma (St. Louis, MO, USA), TCI (Shanghai, China), Merck (Mumbai, India), SRL (New Delhi, India) and Fisher (Pittsburgh, PA, USA).

4.2. Collection and Preparation of A. indica Root Extract

A. indica whole plant was collected from the campus garden of Sri Venkateswara University, Tirupati, India. Plant specimen was authenticated by the Taxonomist, Department of Botany, Sri Venkateswara University, Tirupati and herbarium was deposited with a voucher no: SVU-BOT-926. The roots were separated from the plant, and washed with running tap water to remove soil, then washed again with fresh water and shade dried. The dried root material was powdered using blender, and 100 g of the powder was transferred into amber color bottle containing 500 mL of methanol (1:5). The mixture was incubated with occasional stirring for 3 days, and the solvent was filtered with non-absorbent cotton, muslin cloth and Whatman no 1 filter paper finally. The filtrate was concentrated in rotary evaporator (BUCHI 036576, Roskilde, Denmark) and lyophilized (VIRTIS:Model BT4KZL-105, Midland, Canada) to obtain A. indica root methanolic extract (AIRME).

4.3. Qualitative Estimation of Phytochemicals

We have primarily tested for the phytochemicals of phenols, flavonoids, saponins, tannins, reducing sugars, alkaloids, terpenoids, coumarins anthraquinones and anthocyanins in the AIRME according to the protocols stated by Shukla and colleagues [52].

4.4. Quantitative Estimation of Phytochemicals

4.4.1. Determination of Total Phenolic Content

According to Gutierrez and Navarro [53], the total phenolic content of AIRME was measured using the Folin Ciocalteu (FC) method. Briefly, 0.5 mL (5 mg) of extract at different concentrations (5–50 µg/mL) and same concentrations of standard gallic acid was added to 1 mL of FC (10%) reagent. For this reaction, 2.5 mL of sodium carbonate solution was added and incubated at room temperature for 30 min. Using a UV-Vis spectrophotometer (Shimadzu UV-1800, Kyoto, Japan) the resulting reaction was measured at 760 nm. The gallic acid standard graph was used to calculate the phenolic content of the extract, and expressed as mg of gallic acid equivalent per g of extract.

4.4.2. Determination of Total Flavonoids Content

Total flavonoid content in AIRME was quantified by following aluminum chloride method [54]. Briefly, 1.0 mL of extract (10 mg/mL) was added to 4 mL of distilled water. To this, 0.3 mL of 5% NaNO2 and 0.3 mL of 10% aluminum chloride (AlCl3) solutions were added and incubate for 6 min. Then, 2 mL of 1 M NaOH solution was added and made up to 10 mL with distilled water. The reaction mixture was incubated for another 15 min and the flavonoid content was measured at 510 nm. Rutin was used as standard for calculating flavonoid content in AIRME, and content was expressed as mg of rutin equivalent per g of extract.

4.4.3. Phytochemical Profiling and Gas Chromatography-Mass Spectrometry (GC-MS) analysis of AIRME

GC-MS analysis for AIRME was achieved by JEOL GC MATE ΙΙ (GC model, Agilent Technologies 6890N Network GC system, Santa Clara, CA, USA) equipped with HP 5 MS column. High pure helium as carrier gas at a constant flow rate of 1 mL/min was used for GC separation. Injector temperature was set at 220 °C and oven temperature was set as 50 °C raised to 250 °C at 10 °C/min. Total GC running time was 30 min. A highly sensitive quadruple double focusing mass analyzer was used and equipped with photon multiplier tube as the detector; mass range of 50 to 600 amu; and ionization voltage (Electron impact ionization) 70 eV was used. This protocol was also explained in our previous study [19]. Mass of each peak was obtained from mass spectroscopy while the proposed structures of compounds were predicted from the screening library of National Institute of Standard and Technology (NIST, Gaithersburg, MD, USA).

4.4.4. Phytochemicals Profiling and HR-LC-MS Analysis of AIRME

The AIRME was then analyzed in HR-LC-MS (Model: Agilent 1290 Infinity UHPLC System, Santa Clara, CA, USA) in order to identify the finger prints of other hidden phyto moieties. For this assessment we followed procedure described by Ravi et al., [19]. Briefly, an auto sampler injected a 3 µL volume of the sample into a C18 column (ZORBAX 2.1 9. 50 mm 1.8 Micron). The auto sampler has a 100 µL/mL auxiliary pull and ejects the sample quickly. Two binary pumps (G4220B) are integrated in one housin and deliver desired mobile phase gradient ratios (solvent A: 0.1% Formic Acid (FA) in water and B: 90% Acetonitrile + 10% H2O + 0.1% FA). The total run time was 30 min, during which the solvent A-95% + B-5% was initiated at 2 min, the solvent A gradient ratio changed to 5% at 20 min, and the solvent A 95% was maintained from 26 to 30 min. The binary pump pressure was kept stable at 1200 bar, and the flow rate was 0.300 mL/min. The Mass Hunter workstation program was used to gain an edge in identifying correct MS and MS/MS for the extract’s LC profile.

4.4.5. Computational Calculations for the Identified Phytochemicals

The resulted phytochemicals from analytical techniques were structurally drawn and their chemical descriptors, such as hydrogen bond donor count (HBDC) and hydrogen bond acceptor count (HBAC) were predicted using Marvin Sketch 16.3.21 version (https://chemaxon.com/products/marvin, (accessed on 8 June 2021)), a chemo informatics tool. In addition, the pharmacological properties of these compounds include tumorigenic, mutagenic, irritant and reproductive effects were assessed using DataWarrior V4.7.2 software (http://www.openmolecules.org/datawarrior/, (accessed on 8 June 2021)).

4.5. In Vitro Studies

Free Radical Scavenging and Anti-Lipid Peroxidation Activities of AIRME
In vitro free radical scavenging activity of AIRME was carried out by incubating different concentrations of extract (10–50 µg/mL) with 0.6 mM DPPH. The resulting reaction optical density (OD) was read at 517 nm against ethanol blank [55]. Hydroxyl radical (•OH) scavenging ability of AIRME was assayed by adopting the deoxyribose method as described by Nagai et al., [56]. The •OH radicals of Fentons reagent degrade the deoxyribose sugar, whereas prevention of such degradation of sugar by AIRME was studied with different concentrations (10–50 µg/mL). The OD of samples was read at 520 nm against blank containing total reaction mixture with absence of AIRME.
The hydrogen peroxide (H2O2) inhibition/reduction property of AIRME was carried out by incubating different concentration of extract (20–100 µg/mL) with H2O2 for 30 min. Retained H2O2 after incubation was read at 230 nm against phosphate buffer blank [57] in UV-VIS spectrophotometer (Shimadzu UV-1800, Kyoto, Japan). Next, anti-lipid peroxidation property of AIRME was determined using egg homogenate treated with Fentons reagent for 1 h incubation as described by Upadhyay et al. [58]. Prevention of lipid peroxidation by various concentrations of AIRME (20–100 µg/mL) was read at 532 nm using total reaction without extract as a blank.

4.6. In Vivo Studies

4.6.1. Experimental Design and Treatment

Anti-inflammatory and antioxidant activity of AIRME was studied in 1% carrageenan induced paw edema in rats. Thirty-six male adult rats of Wistar strain were purchased from the Indian Institute of Science (IISc), Bangalore. Rats were kept in cages, allowed to acclimatize for a week with conditions of 25–28 °C temperature, 50–55% humidity, with regular light/dark cycle (7:00 AM to 7:00 PM). Strict ethical guidelines for the maintenance and care of experimental animals were followed. The entire study design and protocols used in this study were reviewed and approved by the Institutional Animal Ethics Committee (09/(i)/a/CPCSEA/IAEC/SVU/ZOOL/KSR/Dt.08/07/2012) of Sri Venkateswara University, Tirupati, India. After acclimatization, rats (190 gm ± 10 gm bodyweight) were divided into six experimental groups with six rats in each as mentioned below:
  • Group I—Normal control (NC): Rats in this group received 50 µL normal saline by sub-plantar injection (SPI);
  • Group II—Disease control (DC): Carrageenan (1%, 100 µL) was injected (SPI) into the rat paw to induce acute localized inflammation;
  • Group III—AIRME control (AIRME): Rats in this group received only AIRME (300 mg/kg bodyweight) by oral gavage;
  • Group IV—AIRME low-dose plus carrageenan (AIRME-L+C): Rats were orally administered with low dose of AIRME (150 mg/kg body weight) through oral gavage 1 h prior to carrageenan injection.;
  • Group V—AIRME high-dose plus carrageenan (AIRME-H+C): Rats in this group received high dose of AIRME (300 mg/kg body weight) 1 h prior to carrageenan injection, as described in group IV;
  • Group VI—Standard treatment (ST): Rats in this group received diclofenac (20 mg/kg body weight) by oral gavage one hour before carrageenan injection.
Carrageenan-induced rat paw edema is a well-established and widely used model to evaluate the anti-inflammatory properly of plant and synthetic compounds [10,21,59]. The AIRME doses (150 and 300 mg/kg body weight) used in this study were based on our preliminary dose-dependent studies, where we found various doses of AIRME (100, 150, 200, 250 and 300 mg/kg bodyweight) did not produce any physiological or behavioral changes in normal rats. Besides Sathya and colleagues documented no adverse with different doses of A. indica ethanolic extracts ranges from 5 to 2000 mg/kg b.w. [60].

4.6.2. Measurement of Paw Volume

The perimeter of the inflamed and AIRME treated paws of experimental animals was measured using digital screw gauge (model: Insize-3109-25s-digital outside micrometer) as described by Killari and team (2019) [61]. The paw volume was measured for every hour until 6 h following carrageenan injection. The percent increase in paw thickness was calculated using the formula (Equation (1)):
Y t − Y 0 Y 0 x × 100
where:
  • Y t —thickness of paw at different time intervals (1, 2, 3, 4, 5 and 6 h) (after carrageenan induction);
  • Y 0 —thickness of paw at 0 h (before injection of carrageenan).
Resulted final value for every group at every hour was obtained through calculated mean.

4.6.3. Blood Collection and Analyses

After treatment period, rats were subjected to chloroform anesthesia and sacrificed with cervical dislocation. On the experiment day, the blood samples (approximately 5 mL) were immediately collected through heart puncture into tubes that contain anti-coagulant (EDTA). In blood, white blood cells (WBC) and platelets were counted using a haemogram. For the CRP assay, blood samples were centrifuged at 4000× g rpm for 15 min, and serum was collected. Then C-reactive protein (CRP) levels were measured in the serum using kit provided by Aspen Laboratories (Himachal Pradesh, India). The changes in CRP in different groups were expressed as ng/mL. The blood collection procedures and assay protocols were approved Institutional Animal Ethics Committee.

4.6.4. Determination of Antioxidant Enzyme Activities in Paw Tissue

Paw tissue was separated, cleaned with normal saline and stored at −40 °C for further biochemical analysis. Antioxidant status of paw tissue was measured by assessing the primary antioxidant enzyme activities. The activity of superoxide dismutase (SOD) in the paw homogenates was measured using the Misra and Fridovich [62] method at 480 nm for 4 min on a Shimadzu UV-1800 spectrophotometer. The activity was measured as the quantity of enzyme that prevents epinephrine from being oxidized by 50%, which was equal to 1 U per mg of protein. Catalase (CAT) activity was evaluated using Aebi, [63] procedure, and the sample’s absorbance was recorded using a UV spectrophotometer at 240 nm for 1 min. The moles of hydrogen peroxide (0.066 M) decomposed per mg of protein each minute equals to one unit activity. The GR activity was measured at 340 nm for 3 min in spectrophotometer. The GR activity was expressed in micromoles of NADPH oxidized per mg of protein per minute [64]. GPx activity of paw tissue was measured using a reaction mixture composed of GSH (0.01 M), 12 mM t-butyl-hyroperoxide, 1.5 mM NADPH, and GR (0.24 units). The mM of NADPH oxidized/mg protein/min was measured at 340 nm for 180 s to determine enzyme activity [65].

4.6.5. Histopathology

The paw tissue biopsy of rats from all experimental groups were taken and fixed in 10% formalin to prevent autolysis, which permanently cross-links and stabilizes their proteins. Then, the paw tissue was decalcified with weak formic acid before trimming to acquire the proper size and orientation of tissue (10%). The tissue sample was also infiltrated with paraffin to obtain its water content before being embedded in paraffin. Then the tissue embedded in paraffin was sliced into 6–8 μm section cuttings in a microtome as described by Slaoui and Fiette [66]. Further, tissue sections were stained with hematoxylin and eosin (H&E) on glass slide. The histopathological changes in paw tissue sections were observed under the microscope (Trinocular BX53, Olympus, Singapore) and the changes were recorded at 40× magnification.

4.7. Statistical Analysis

We used SPSS (Version 15, SPSS Inc., Chicago, IL, USA) and Excel for statistical analyses. The data expressed as means ± standard deviation (SD). One-way analysis of variance (ANOVA), followed by Duncan’s multiple comparison tests were performed for group comparison and significance. Statistical significance was set at p < 0.05.

5. Conclusions

For the first time, we demonstrated that A. indica root extract is rich in various phytochemical constituents without adverse effect descriptors. The major phytomolecules are ramipril glucuronide, antimycin A, swietenine, quinone, oxprenolol, choline, bumetanide and fenofibrate. AIRME showed potent free radical scavenging activity (DPPH and •OH) and inhibition of lipid peroxidation ability. AIRME pretreatment diminished carrageenan-induced paw edema, and decreased WBC, platelets and CRP levels in rats. Improved antioxidant status with AIRME was further confirmed by its tissue protective effects against acute inflammatory damage. Owing to the potent antioxidant and anti-inflammatory properties of AIRME, our findings suggest considering of AIRME in developing and preparation of novel anti-inflammatory drugs. However, further studies are necessary to explore in-depth molecular mechanism with specific known compounds of A. indica root extract.

Supplementary Materials

The following are available online, Figure S1: Chromatogram obtained for AIRME from HR-LC-MS, Figure S2: Chromatogram obtained for AIRME from GC-MS and Figure S3: Chemical structures of AIRME obtained from both HR-LC-MS and GC-MS.

Author Contributions

Conceptualization, R.S., S.R.K. and M.K.; methodology and analyses, R.S., J.P., S.B. and V.S.G.; data curation and visualization, S.K.R., W.Y. and R.S.; writing—original draft preparation, R.S. and J.P.; writing—review, editing and finalizing, S.R.K., W.Y. and M.K.; supervision, S.R.K. and M.K.; project administration and funding acquisition, R.S. and S.R.K. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the University Grants Commission (UGC), New Delhi, India in the form of RGNF with grant numbers F117.1/2012-13/RGNF-2012-13-SC-AND 34335 (R.S.) and F1-17.1/2015-16/RGNF-2015-17-SC-AND-17449 (J.P.). This study was further supported by BSR-Faculty Fellowship with grant number F.18-1/2011 (BSR), dated 24-11-2017 (S.R.K).

Institutional Review Board Statement

This study was performed in accordance with the institutional animal care and use committee, Sri Venkateswara University, India. The study design and protocols used in this study were reviewed and approved by the Institutional Animal Ethical Committee (09/(i)/a/CPCSEA/IAEC/SVU/ ZOOL/KSR/Dt.08/07/2012).

Data Availability Statement

The data presented in this study are available from the corresponding authors on request.

Acknowledgments

Authors are thankful to the Sophisticated Analytical Instrument Facility (SAIF), Indian Institute of Technology (IIT), Madras (Chennai) and IIT Bombay (Mumbai), India for helping to run the HR-LC-MS and GC-MS analyses.

Conflicts of Interest

All authors declared that there are no conflict of interest.

Sample Availability

Samples of the plant extract with phytochemical composition are available from the authors.

References

  1. Mozafari, N.; Azadi, S.; Mehdi-Alamdarlou, S.; Ashrafi, H.; Azadi, A. Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin. Med. Hypotheses 2020, 143, 110111. [Google Scholar] [CrossRef]
  2. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free. Radic. Biol. Med. 2010, 49, 1603–1616. [Google Scholar] [CrossRef] [Green Version]
  3. Leick, M.; Azcutia, V.; Newton, G.; Luscinskas, F.W. Leukocyte recruitment in inflammation: Basic concepts and new mechanistic insights based on new models and microscopic imaging technologies. Cell Tissue Res. 2014, 355, 647–656. [Google Scholar] [CrossRef]
  4. Mittal, M.; Siddiqui, M.R.; Tran, K.; Reddy, S.P.; Malik, A.B. Reactive Oxygen Species in Inflammation and Tissue Injury. Antioxidants Redox Signal. 2014, 20, 1126–1167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Schieber, M.; Chandel, N.S. ROS Function in Redox Signaling and Oxidative Stress. Curr. Biol. 2014, 24, R453–R462. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Yang, H.-L.; Korivi, M.; Lin, M.-K.; Chang, H.C.-W.; Wu, C.-R.; Lee, M.-S.; Chen, W.T.-L.; Hseu, Y.-C. Antihemolytic and antioxidant properties of pearl powder against 2,2′-azobis(2-amidinopropane) dihydrochloride-induced hemolysis and oxidative damage to erythrocyte membrane lipids and proteins. J. Food Drug Anal. 2017, 25, 898–907. [Google Scholar] [CrossRef]
  7. Ali, N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J. Med. Virol. 2020, 92, 2409–2411. [Google Scholar] [CrossRef] [PubMed]
  8. Sproston, N.R.; Ashworth, J.J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol. 2018, 9, 754. [Google Scholar] [CrossRef] [PubMed]
  9. Geronikaki, A.A.; Gavalas, A.M. Antioxidants and inflammatory disease: Synthetic and natural antioxidants with anti-inflammatory activity. Comb. Chem. High Throughput Screen. 2006, 9, 425–442. [Google Scholar] [CrossRef]
  10. Rezq, S.; Mahmoud, M.; El-Shazly, A.; El Raey, M.; Sobeh, M. Anti-Inflammatory, Antipyretic, and Analgesic Properties of Potamogeton perfoliatus Extract: In Vitro and In Vivo Study. Molecules 2021, 26, 4826. [Google Scholar] [CrossRef]
  11. Ekor, M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014, 4, 177. [Google Scholar] [CrossRef] [Green Version]
  12. Tungmunnithum, D.; Thongboonyou, A.; Pholboon, A.; Yangsabai, A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. Medicines 2018, 5, 93. [Google Scholar] [CrossRef]
  13. Carvalho, A.; Heimfarth, L.; Pereira, E.; Oliveira, F.S.; Menezes, I.; Coutinho, H.D.M.; Picot, L.; Antoniolli, A.R.; Quintans, L.; Quintans-Júnior, L.J. Phytol, a Chlorophyll Component, Produces Antihyperalgesic, Anti-inflammatory, and Antiarthritic Effects: Possible NFκB Pathway Involvement and Reduced Levels of the Proinflammatory Cytokines TNF-α and IL-6. J. Nat. Prod. 2020, 83, 1107–1117. [Google Scholar] [CrossRef]
  14. Cavalcanti, M.R.M.; Passos, F.R.S.; Monteiro, B.S.; Gandhi, S.R.; Heimfarth, L.; Lima, B.S.; Nascimento, Y.M.; Duarte, M.C.; Araujo, A.A.S.; Menezes, I.R.A.; et al. HPLC-DAD-UV analysis, anti-inflammatory and anti-neuropathic effects of methanolic extract of Sideritis bilgeriana (lamiaceae) by NF-κB, TNF-α, IL-1β and IL-6 involvement. J. Ethnopharmacol. 2021, 265, 113338. [Google Scholar] [CrossRef]
  15. Van Valkenburg, J.; Bunyapraphatsara, N. Plant resources of South-East Asia No. 12 (2): Medicinal and poisonous plants 2. Backhuys Publishers. Nord. J. Bot. 2001, 21, 580. [Google Scholar]
  16. Zahidin, N.S.; Saidin, S.; Zulkifli, R.M.; Muhamad, I.I.; Ya’Akob, H.; Nur, H. A review of Acalypha indica L. (Euphorbiaceae) as traditional medicinal plant and its therapeutic potential. J. Ethnopharmacol. 2017, 207, 146–173. [Google Scholar] [CrossRef] [PubMed]
  17. Govindarajan, M.; Jebanesan, A.; Reetha, D.; Amsath, R.; Pushpanathan, T.; Samidurai, K. Antibacterial activity of Acalypha indica L. Eur. Rev. Med. Pharmacol. Sci. 2008, 12, 299–302. [Google Scholar] [PubMed]
  18. Kameswari, S.; Narayanan, A.L.; Rajeshkumar, S. Free radical scavenging and anti-inflammatory potential of Acalypha indica mediated selenium nanoparticles. Drug Invent. Today 2020, 13, 106–112. [Google Scholar]
  19. Ravi, S.; Shanmugam, B.; Subbaiah, G.V.; Prasad, S.H.; Reddy, K.S. Identification of food preservative, stress relief compounds by GC–MS and HR-LC/Q-TOF/MS; evaluation of antioxidant activity of Acalypha indica leaves methanolic extract (in vitro) and polyphenolic fraction (in vivo). J. Food Sci. Technol. 2017, 54, 1585–1596. [Google Scholar] [CrossRef] [Green Version]
  20. Rao, K.V.B.; Priya, C.L. Postprandial antihyperglycemic and antioxidant activities of Acalypha indica Linn stem extract: An in-vivo study. Pharmacogn. Mag. 2016, 12, 475–S481. [Google Scholar] [CrossRef] [Green Version]
  21. Patil, K.R.; Mahajan, U.B.; Unger, B.S.; Goyal, S.N.; Belemkar, S.; Surana, S.J.; Ojha, S.; Patil, C.R. Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals. Int. J. Mol. Sci. 2019, 20, 4367. [Google Scholar] [CrossRef] [Green Version]
  22. El Jemli, M.; Kamal, R.; Marmouzi, I.; Zerrouki, A.; Cherrah, Y.; Alaoui, K. Radical-Scavenging Activity and Ferric Reducing Ability of Juniperus thurifera (L.), J. oxycedrus (L.), J. phoenicea (L.) and Tetraclinis articulata (L.). Adv. Pharmacol. Sci. 2016, 2016, 1–6. [Google Scholar] [CrossRef] [Green Version]
  23. Masella, R.; Di Benedetto, R.; Varì, R.; Filesi, C.; Giovannini, C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 2005, 16, 577–586. [Google Scholar] [CrossRef]
  24. Quan, V.V.; Nam, P.C.; Thong, N.M.; Trung, N.T.; Phan, C.-T.D.; Mechler, A. Antioxidant Motifs in Flavonoids: O–H versus C–H Bond Dissociation. ACS Omega 2019, 4, 8935–8942. [Google Scholar]
  25. Halliwell, B.; Gutteridge, J.M. Free Radicals in Biology and Medicine; Oxford University Press: Oxford, UK, 2015; p. 905. [Google Scholar]
  26. Korivi, M.; Chen, C.-T.; Yu, S.-H.; Ye, W.; Cheng, I.-S.; Chang, J.-S.; Kuo, C.-H.; Hou, C.-W. Seaweed Supplementation Enhances Maximal Muscular Strength and Attenuates Resistance Exercise-Induced Oxidative Stress in Rats. Evid. Based Complementary Altern. Med. 2019, 2019, 3528932–3528939. [Google Scholar] [CrossRef]
  27. Chen, K.-N.; Peng, W.-H.; Hou, C.-W.; Chen, C.-Y.; Chen, H.-H.; Kuo, C.-H.; Korivi, M. Codonopsis javanica root extracts attenuate hyperinsulinemia and lipid peroxidation in fructose-fed insulin resistant rats. J. Food Drug Anal. 2013, 21, 347–355. [Google Scholar] [CrossRef] [Green Version]
  28. Krewski, D.; Acosta, D.; Andersen, M.; Anderson, H.; Bailar, J.C.; Boekelheide, K.; Brent, R.; Charnley, G.; Cheung, V.G.; Green, S.; et al. Toxicity Testing in the 21st Century: A Vision and a Strategy. J. Toxicol. Environ. Health Part B 2010, 13, 51–138. [Google Scholar] [CrossRef] [PubMed]
  29. Posadas, I.; Bucci, M.; Roviezzo, F.; Rossi, A.; Parente, L.; Sautebin, L.; Cirino, G. Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br. J. Pharmacol. 2004, 142, 331–338. [Google Scholar] [CrossRef]
  30. Sugimoto, M.A.; Sousa, L.; Pinho, V.; Perretti, M.; Teixeira, M.M. Resolution of Inflammation: What Controls Its Onset? Front. Immunol. 2016, 7, 160. [Google Scholar] [CrossRef] [Green Version]
  31. Bhattacharyya, S.; Dudeja, P.K.; Tobacman, J.K. Carrageenan-induced NFκB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim. Biophys. Acta Bioenerg. 2008, 1780, 973–982. [Google Scholar] [CrossRef] [Green Version]
  32. Winter, C.A.; Risley, E.A.; Nuss, G.W. Carrageenin-Induced Edema in Hind Paw of the Rat as an Assay for Antiinflammatory Drugs. Exp. Biol. Med. 1962, 111, 544–547. [Google Scholar] [CrossRef]
  33. Perianayagam, J.B.; Sharma, S.; Pillai, K. Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals. J. Ethnopharmacol. 2006, 104, 410–414. [Google Scholar] [CrossRef]
  34. Duwiejua, M.; Woode, E.; Obiri, D. Pseudo-akuammigine, an alkaloid from Picralima nitida seeds, has anti-inflammatory and analgesic actions in rats. J. Ethnopharmacol. 2002, 81, 73–79. [Google Scholar] [CrossRef]
  35. Handy, R.L.C.; Moore, P.K. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br. J. Pharmacol. 1998, 123, 1119–1126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Sonmez, O.; Sonmez, M. Role of platelets in immune system and inflammation. Porto Biomed. J. 2017, 2, 311–314. [Google Scholar] [CrossRef] [PubMed]
  37. Black, S.; Kushner, I.; Samols, D. C-reactive protein. J. Biol. Chem. 2004, 279, 48487–48490. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Sato, A.; Oe, K.; Yamanaka, H.; Yokoyama, I.; Ebina, K. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo. Eur. J. Pharmacol. 2014, 745, 46–51. [Google Scholar] [CrossRef]
  39. Pan, Z.-Y.; Wang, H. Synergistic interaction between choline and aspirin against acute inflammation induced by carrageenan and lipopolysaccharide. Int. Immunopharmacol. 2014, 20, 229–237. [Google Scholar] [CrossRef]
  40. Willis, E.F.; Clough, G.F.; Church, M.K. Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin. Exp. Allergy 2004, 34, 450–455. [Google Scholar] [CrossRef]
  41. Belfort, R.; Berria, R.; Cornell, J.; Cusi, K. Fenofibrate Reduces Systemic Inflammation Markers Independent of Its Effects on Lipid and Glucose Metabolism in Patients with the Metabolic Syndrome. J. Clin. Endocrinol. Metab. 2010, 95, 829–836. [Google Scholar] [CrossRef] [Green Version]
  42. Mak, K.-K.; Shiming, Z.; Balijepalli, M.K.; Dinkova-Kostova, A.T.; Epemolu, O.; Mohd, Z.; Pichika, M.R. Studies on the mechanism of anti-inflammatory action of swietenine, a tetranortriterpenoid isolated from Swietenia macrophylla seeds. Phytomed. Plus 2021, 1, 100018. [Google Scholar] [CrossRef]
  43. Barth, C.R.; Funchal, G.A.; Luft, C.; de Oliveira, J.R.; Porto, B.N.; Donadio, M.V.F. Carrageenan-induced inflammation promotes ROS generation and neutrophil extracellular trap formation in a mouse model of peritonitis. Eur. J. Immunol. 2016, 46, 964–970. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Del Maestro, R. Free Radicals as Mediators of Tissue Injury. Acta Physiol Scand Suppl. 1980, 492, 43–57. [Google Scholar] [PubMed]
  45. Halici, Z.; Dengiz, G.O.; Odabasoglu, F.; Suleyman, H.; Cadirci, E.; Halici, M. Amiodarone has anti-inflammatory and anti-oxidative properties: An experimental study in rats with carrageenan-induced paw edema. Eur. J. Pharmacol. 2007, 566, 215–221. [Google Scholar] [CrossRef] [PubMed]
  46. Ben Khedir, S.; Mzid, M.; Bardaa, S.; Moalla, D.; Sahnoun, Z.; Rebai, T. In vivo evaluation of the anti-tnflammatory effect of Pistacia lentiscus fruit oil and its effects on oxidative stress. Evid. Based Complementary Altern. Med. 2016, 2016, 6108203. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Cordaro, M.; Siracusa, R.; Fusco, R.; D’Amico, R.; Peritore, A.F.; Gugliandolo, E.; Genovese, T.; Scuto, M.; Crupi, R.; Mandalari, G.; et al. Cashew (Anacardium occidentale L.) Nuts Counteract Oxidative Stress and Inflammation in an Acute Experimental Model of Carrageenan-Induced Paw Edema. Antioxidants 2020, 9, 660. [Google Scholar] [CrossRef]
  48. Tamaddonfard, E.; Farshid, A.A.; Hosseini, L. Crocin alleviates the local paw edema induced by histamine in rats. Avicenna J. Phytomed. 2012, 2, 97. [Google Scholar]
  49. Naik, R.; Nemani, H.; Pothani, S.; Pothana, S.; Satyavani, M.; Qadri, S.S.; Srinivas, M.; Parim, B. Obesity-alleviating capabilities of Acalypha indica, Pergulari ademia and Tinospora cardifolia leaves methanolic extracts in WNIN/GR-Ob rats. J. Nutr. Intermed. Metab. 2019, 16, 100090. [Google Scholar] [CrossRef]
  50. Santos, F.; Rao, V.S. A Study of the Anti-pyretic Effect of Quinine, an Alkaloid Effective Against Cerebral Malaria, on Fever Induced by Bacterial Endotoxin and Yeast in Rats. J. Pharm. Pharmacol. 2011, 50, 225–229. [Google Scholar] [CrossRef]
  51. Alblihed, M.A. Astragalin attenuates oxidative stress and acute inflammatory responses in carrageenan-induced paw edema in mice. Mol. Biol. Rep. 2020, 47, 6611–6620. [Google Scholar] [CrossRef]
  52. Shukla, A.; Vats, S.; Shukla, R. Phytochemical Screening, proximate analysis and antioxidant activity of Dracaena reflexa lam. leaves. Indian J. Pharm. Sci. 2015, 77, 640–644. [Google Scholar] [CrossRef] [Green Version]
  53. Gutierrez, R.M.P.; Navarro, Y.T.G. Antioxidant and hepatoprotective effects of the methanol extract of the leaves ofSatureja macrostema. Pharmacogn. Mag. 2010, 6, 125–131. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Chang, C.-C.; Yang, M.-H.; Wen, H.-M.; Chern, J.-C. Estimation of total flavonoid content in propolis by two complementary colometric methods. J. Food Drug Anal. 2002, 10, 3. [Google Scholar] [CrossRef]
  55. Gyamfi, M.A.; Yonamine, M.; Aniya, Y. Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries. Gen. Pharmacol. Vasc. Syst. 1999, 32, 661–667. [Google Scholar] [CrossRef]
  56. Nagai, T.; Myoda, T.; Nagashima, T. Antioxidative activities of water extract and ethanol extract from field horsetail (tsukushi) Equisetum arvense L. Food Chem. 2005, 91, 389–394. [Google Scholar] [CrossRef]
  57. Esmaeili, M.A.; Sonboli, A. Antioxidant, free radical scavenging activities of Salvia brachyantha and its protective effect against oxidative cardiac cell injury. Food Chem. Toxicol. 2010, 48, 846–853. [Google Scholar] [CrossRef]
  58. Upadhyay, R.; Chaurasia, J.K.; Tiwari, K.N.; Singh, K. Antioxidant Property of Aerial Parts and Root ofPhyllanthus fraternusWebster, an Important Medicinal Plant. Sci. World J. 2014, 2014, 1–7. [Google Scholar] [CrossRef] [Green Version]
  59. Adnan; Chy, N.U.; Kamal, A.M.; Barlow, J.W.; Faruque, M.O.; Yang, X.; Uddin, S.B. Evaluation of anti-nociceptive and anti-inflammatory activities of the methanol extract of Holigarna caustica (Dennst.) Oken leaves. J. Ethnopharmacol. 2019, 236, 401–411. [Google Scholar] [CrossRef]
  60. Sathya, M.; Kokilavani, R.; Ananta Teepa, K. Acute and subacute toxicity studies of ethanolic extract of Acalypha indica Linn in male Wistar albino rats. Asian J. Pharm. Clin. Res. 2012, 5, 97–100. [Google Scholar]
  61. Killari, K.N.; Prasad, K.; Talluri, M.R.; Bokam, Y.K.; Nadiminti, S.R.; Kommavari, C.S. Antiinflammatory Activity of Wheat Grass Fortified with Cow Urine Distillate. Indian J. Pharm. Sci. 2019, 81, 521–526. [Google Scholar] [CrossRef] [Green Version]
  62. Misra, H.P.; Fridovich, I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247, 3170–3175. [Google Scholar] [CrossRef]
  63. Aebi, H. Catalase in vitro. Methods Enzymol. 1984, 105, 121–126. [Google Scholar] [CrossRef] [PubMed]
  64. Carlberg, I.; Mannervik, B. Glutathione reductase. Methods Enzymol. 1985, 113, 484–490. [Google Scholar] [PubMed]
  65. Flohé, L.; Günzler, W.A. Assays of glutathione peroxidase. Methods Enzymol. 1984, 105, 114–120. [Google Scholar] [CrossRef] [PubMed]
  66. Slaoui, M.; Fiette, L. Histopathology Procedures: From Tissue Sampling to Histopathological Evaluation. In Methods in Molecular Biology; Springer Science and Business Media LLC: Berlin/Heidelberg, Germany, 2011; Volume 691, pp. 69–82. [Google Scholar]
Molecules 26 06251 g001 550
Figure 1. Percent changes in paw volume during the time course of 6 h after carrageenan injection (acute inflammation) in control and AIRME pretreated groups. Values are significant compared with control ($ p < 0.05) and compared with carrageenan-injected group (** p < 0.01). NC, normal control; DC, disease control; AIRME, A. indica root methanolic extract; AIRME-L+C, AIRME-low-dose plus carrageenan; AIRME-H+C, AIRME-high-dose plus carrageenan; ST, standard treatment.
Figure 1. Percent changes in paw volume during the time course of 6 h after carrageenan injection (acute inflammation) in control and AIRME pretreated groups. Values are significant compared with control ($ p < 0.05) and compared with carrageenan-injected group (** p < 0.01). NC, normal control; DC, disease control; AIRME, A. indica root methanolic extract; AIRME-L+C, AIRME-low-dose plus carrageenan; AIRME-H+C, AIRME-high-dose plus carrageenan; ST, standard treatment.
Molecules 26 06251 g001
Molecules 26 06251 g002 550
Figure 2. Physiological changes in rat paw tissue following carrageenan injection (1%) in different groups with or without AIRME 150. mg/kg), AIRME-H+C (300 mg/kg) and diclofenac (ST) pretreated rats. NC, normal control; DC, disease control; AIRME, A. indica root methanolic extract; AIRME-L+C, AIRME-low-dose plus carrageenan; AIRME-H+C, AIRME-high-dose plus carrageenan; ST, standard treatment.
Figure 2. Physiological changes in rat paw tissue following carrageenan injection (1%) in different groups with or without AIRME 150. mg/kg), AIRME-H+C (300 mg/kg) and diclofenac (ST) pretreated rats. NC, normal control; DC, disease control; AIRME, A. indica root methanolic extract; AIRME-L+C, AIRME-low-dose plus carrageenan; AIRME-H+C, AIRME-high-dose plus carrageenan; ST, standard treatment.
Molecules 26 06251 g002
Molecules 26 06251 g003 550
Figure 3. Changes in antioxidant enzyme (superoxide dismutase (a), catalase (b), glutathione reductase (c), glutathione peroxidase (d)) activities in paw tissues of different groups of rats. NC, normal control; DC, disease control (carrageenan); AIRME, Acalypha indica root methanolic extract; AIRME-L+C (AIRME low dose plus carrageenan); AIRME-H+C (AIRME high dose plus carrageenan), and ST (standard treatment, diclofenac). All values represented as mean ± SD (n = 6). $ indicates significant (p < 0.05) difference with NC. * (p < 0.05) and ** (p < 0.01) indicates significant difference with DC.
Figure 3. Changes in antioxidant enzyme (superoxide dismutase (a), catalase (b), glutathione reductase (c), glutathione peroxidase (d)) activities in paw tissues of different groups of rats. NC, normal control; DC, disease control (carrageenan); AIRME, Acalypha indica root methanolic extract; AIRME-L+C (AIRME low dose plus carrageenan); AIRME-H+C (AIRME high dose plus carrageenan), and ST (standard treatment, diclofenac). All values represented as mean ± SD (n = 6). $ indicates significant (p < 0.05) difference with NC. * (p < 0.05) and ** (p < 0.01) indicates significant difference with DC.
Molecules 26 06251 g003
Molecules 26 06251 g004 550
Figure 4. Histopathological study of inflamed paw tissue treated with AIRME. Paw tissue in NC and AIRME groups showed normal appearance of muscle (M) around the decalcified bone (DB), no vascular dilation (NV) and no infiltrate.
Figure 4. Histopathological study of inflamed paw tissue treated with AIRME. Paw tissue in NC and AIRME groups showed normal appearance of muscle (M) around the decalcified bone (DB), no vascular dilation (NV) and no infiltrate.
Molecules 26 06251 g004
Table
Table 1. Phytochemical profile of AIRME using chromatography techniques (HR-LC-MS and GC-MS), antioxidant descriptors (Hbds—Hydrogen bond donor count and Hbas—Hydrogen bond acceptors count) and adverse properties (Mut—mutagenicity, Tum—tumarogenicity, Irri—irritant and RepTox—reproductive toxicology) predicted using Marvin sketch, a computational tool.
Table 1. Phytochemical profile of AIRME using chromatography techniques (HR-LC-MS and GC-MS), antioxidant descriptors (Hbds—Hydrogen bond donor count and Hbas—Hydrogen bond acceptors count) and adverse properties (Mut—mutagenicity, Tum—tumarogenicity, Irri—irritant and RepTox—reproductive toxicology) predicted using Marvin sketch, a computational tool.
NoCompounds Identified by HR-LC-MS RTFormulaMassHbdsHbasMutTumIrriRepToxPubChem CIDPercentage
1Oxtriphylline 0.42C12H22N5O3284.171514NoNoNoNo6566520.677
2Choline 0.501C5H14NO104.107412NoNoNoNo62090.847
3Bumetanide 0.612C17H20N2O5S364.111237NoNoYesNo24710.847
4Indospicine0.612C7H15N3O2173.116544NoNoYesNo1080100.776
510-Hydroxy-2E,8E-Decadiene-4,6-diynoic acid0.613C10H12O3180.077222NoNoYes No95436160.745
62,6-Piperidinedicarboxylic acid0.615C7H11NO4173.06924No No No Yes5575150.881
7Ala Ser His0.616C12H19N5O5313.139267NoNoNoNo-0.644
8Arg Pro0.656C11H21N5O3271.165257NoNoNoNo-0.677
9His Gly Val0.658C13H21N5O4311.157756NoNoNoNo-0.627
10Pro Ile0.662C11H20N2O3228.145944NoNoNoNo-0.661
11Fenofibrate 0.669C20H21ClO4360.11603NoNoNoNo33390.711
12Mycophenolic Acid0.671C17H20O6320.123925NoNoNoNo4465410.881
13Mimosine 0.673C8H10N2O4198.064236lowNoNoNo4404730.911
14Dimethylglycine 0.684C4H9NO2103.063413NoNoNoNo6730.640
153,7-Epoxycaryophyllan-6-one0.688C15H24O2236.175902No No No No 43305300.745
16l-2-Aminoadipic acid0.778C6H11NO4161.068635NoNoNoNo921360.474
17Trans-4-Hydroxy-L-proline0.869C5H9NO3131.05834NoNoNoNo58100.372
18N2-Succinylglutamic acid0.883C9H13NO7247.069447NoNoNoNo252443830.406
19Mucronulatol((+/−))1.157C17H18O5302.11125NoNoNoYes4428110.372
20Propionylglycine methyl ester1.698C6H11NO3145.073812NoNoNoNo-1.186
21Ile Tyr1.744C15H22N2O4294.157546NoNoNoNo-0.847
22Phendimetrazine1.855C12H17NO191.13102NoNoNoNo304871.016
234-(2-Hydroxy-3-isopropylaminopropyl)benzoic acid2.163C13H19NO4253.131335NoNoNoNo-0.406
24Mexiletine2.219C11H17NO179.130901NoNoYesNo41780.406
25N-(3-Oxo-octanoyl)homoserine lactone2.753C12H19NO4241.133513NoNoYesNo1272930.474
26Retusoquinone3.071C11H12O160.087201NoNoNoNo61115641.694
27Peucenin3.385C15H16O4260.10324NoNoNoNo684770.949
28Dehydrovariabilin3.494C17H14O4282.084503NoNoNoYes6247851.050
29Normeperidine3.598C14H19NO2233.141412NoNoNoNo324140.881
30Thr Ala Ser3.605C10H19N3O6277.131167NoNoNoNo-1.016
31Diethyl Oxalpropionate3.711C9H14O5202.084203NoNoNoNo977500.881
323-O-Methylrimiterol3.763C13H19NO3237.136634NoNoNoNo-1.118
33Citrulline n-butyl ester4.092C10H21N3O3231.158233NoNoYesNo64269710.542
342(Benzylmethylamino)Ethanol N-Oxide4.126C10H15NO2181.110212NoNoNoNo2649960.372
35Chloramphenicol alcohol4.177C11H14N2O6270.084546YesNoNoNo101071470.406
3612-Aminododecanoic acid4.41C12H25NO2215.189123NoNoNoNo696610.745
373-Oxa-9azoniatricyclo[3.3.1.02,4]non ane, 9-ethyl-9-methyl-7[(phenylacetyl)oxy]4.522C18H24NO3302.175714NoNoNoNo-0.542
383,11-Dihydroxy myristoic acid4.835C14H28O4260.200234No No No No 52829230.881
39Avocadene acetate4.835C19H36O4328.262223NoNoYesNo36249800.881
40Sulindac sulfide4.881C20H17FO2S340.090212NoNoNoNo53526241.013
416-Methoxyquinoline4.928C10H9NO159.068602YesNoNoNo148601.288
42Edrophonium4.928C10H16NO166.123311NoNoNoNo32021.220
43Quinine4.939C20H24N2O2324.183714NoNoNoNo30340341.152
443-[2(Dimethylamino)ethoxy]phen ylmethyl]-4-methyl-phenol5.11C18H23NO2285.17313No No No No -1.050
45Metyrapol5.301C14H16N2O228.129213NoNoNoNo1612100.949
46Oxprenolol5.322C15H23NO3265.168227NoNoYesNo46311.118
47Oxyphencyclimine5.541C20H28N2O3344.209416NoNoNoNo46420.986
48Oxycodone6.166C18H21NO4315.148619NoNoNoNo52846030.406
49Ergoline-8-methanol, 10-methoxy-1,6-dimethyl6.279C18H24N2O2300.185813NoNoNoYes-0.847
50Evoxine6.332C18H21NO6347.136210NoNoNoNo734160.542
512-Hydroxytrimipramine6.339C20H26N2O310.203813NoNoNoNo1606100.474
52Penbutolol6.575C18H29NO2291.219625YesNoNoNo374641.152
53Ala Lys Ile6.581C15H30N4O4330.23710NoNoNoNo-1.322
54Oxymorphone6.76C17H19NO4301.13129NoNoNoNo52846040.334
55Diamorphine (heroin)6.762C21H23NO5369.156607NoNoNoYes54623280.406
56Terbinafine metabolite6.911C19H23NO3313.167235NoNoNoNo-1.098
57Strychnine6.912C21H22N2O2334.167205NoNoNoNo4410711.050
58Hydrolysis product of bussein7.021C32H40O14648.241826NoNolowNo546993991.145
59Ambelline7.026C18H21NO5331.141209YesNoNoNo250923661.321
602-Pyrrolidinone, 4-(2aminoethyl)-1-ethyl-3,3diphenyl-(AHR 5904)7.039C20H24N2O308.188223No No No No 1649171.023
61Glu Val Asp7.221C14H23N3O8361.1518717NoNoNoNo-0.953
6210-Nitro,9Z,12Zoctadecadienoic acid7.339C18H31NO4325.224618NoNoNoNo52822590.994
635β-Chol-2-en-24oic Acid7.397C24H38O2358.295414NoNoNoNo-0.912
645α-Cholan-24oic Acid7.733C24H40O2360.31114NoNoNoNo52838020.832
65Etioporphyrin III7.793C32H38N4478.31724NoNoNoNo1413100.814
66Coproporphyrin II8.066C36H38N4O8654.2548610NoNoNoNo1650720.964
67Arg Ala Arg8.473 C15H31N9O4401.25521515NoNoNoNo-0.456
68(5Z)-4,4-difluoro1alpha,25-dihydroxyvitamin D3/(5Z)-4,4-difluoro1alpha, 25dihydroxycholecalcifer8.766C27H42F2O3452.30436No No No No -0.754
69Arg Val Pro8.887C16H30N6O4370.2321812NoNoNoNo-1.101
70Dihydrodeoxystreptomycin9.017C21H41N7O11567.28621629NoNoNoNo119538241.021
71Swietenine9.019C32H40O9568.2704110NoNoNoNo763274651.134
72C16 Sphinganine9.686C16H35NO2273.26633NoNoNoNo52835720.786
73(Z)-N-(2hydroxyethyl)hexadec-7-11.085 297.265822No No No No -0.354
74N-Hexadecyl-l-hydroxyproline11.684C21H41NO3355.30734NoNoNoNo666907360.834
75Trihexyphenidyl N-oxide12.227C20H31NO2317.234212NoNoNoNo1293184570.965
76Zearalenone12.772C18H22O5318.147824NoNoNoNo52815760.236
77GPEtn(10:0/11:0)[U]12.813C26H52NO8P537.339924NoNoNoNo-0.875
7825-Hydroxycholesterol(d3)12.829C27H43D3O2405.360722NoNolowNo-0.823
79Disopyramide13.729C21H29N3O339.239513NoNoNoNo31140.787
8012-Hydroxy-10octadecynoic acid13.763C18H32O3296.234123NoNoNoNo-0.867
81Anandamide (18:3, n-6)14.295C20H35NO2321.265222NoNoNoNo52834450.564
829-Hydroxy-12-oxo10-octadecenoic acid14.4C18H32O4312.228724NoNoNoNo52829680.753
8313-OxoODE14.417C18H30O3294.218413NoNoYesNo52830120.700
842R-hydroxy9Z,12Z,15Z-octadecatrienoic acid14.648C18H30O3294.218823No No No No 160610581.032
85Lactone of PGFMUM14.85C16H24O5296.161214NoNoNoNo-0.854
86N Acetylsphingosine15.403C20H39NO3341.291533NoNoNoNo54971361.132
87Phytosphingosine16.285C18H39NO3317.291844NoNoNoNo1221210.126
88Dihydroceramide C216.767C20H41NO3343.307333NoNoNoNo66102730.453
893-Deacetyl Khivorin16.926C30H40O9544.266715NoNoNoNo468788920.763
90Harderoporphyrin17.931C35H36N4O6608.259458NoNoNoNo30814620.998
91His Arg Val18.001C17H30N8O4410.241189NoNoNoNo-0.324
92Harderoporphyrinogen18.177C35H42N4O6614.311549NoNoYesNo1938250.231
93Ramipril glucuronide18.404C29H40N2O11592.2643510NoNoNoNo-1.563
94Deoxykhivorin18.791C32H42O9570.28204NoNoNoNo67087220.232
95Antimycin A (A1 shown)19.021C27H38N2O9534.259236NoNoYesNo125501.324
96N-(2hydroxyethyl)icosanamide19.051C22H45NO2355.343222NoNoNoNo37872941.021
979,14,19,19,19Pentadeuterio-1α,25dihydroxyprevitamin D3 / 9,14,19,19,19-pentadeuterio1alpha,2519.24C27H39D5O3421.35511NoNolowNo-1.240
982Tricosanamidoethanesulfonic acid19.241C25H51NO4S461.348924No No No No -1.200
99Trandolapril glucuronide20.16C30H42N2O11606.2793510NoNoNoNo920239600.932
1002,4,6-Trimethyl-2,15tetracosadienoic acid20.184C27H50O2406.382112No No No No -0.901
1013β,6α,7αTrihydroxy-5β-cholan-24oic Acid20.754C24H40O5408.284545No No No No -0.875
Compounds Identified by GC-MS
1Piperidine-2,5-dione8.97C5H7NO2113.04712NoNoNoNo5339303.733
2Phenol, 2,4-bis(1,1-dimethylethyl)-12.53C14H22O206.16711NoNoNoNo5289371.333
3Tridecanoic acid,12-methyl-, methyl ester14.92C15H30O2242.22401NoNoNoNo212041.200
41-Oxacyclopentadecan-2-one,15,15-dimethyl15.63C16H30O2254.22401NoNoNoNo-0.800
511-Hexadecenoic acid, methyl ester16.88C17H32O2268.2401NoNoNoNo53646961.040
6Pentadecanoic acid, 14-methyl-, methyl ester17.08C17H34O2270.25501NoNoNoNo212051.493
7Octadecanoic acid17.78C19H38O2298.28701NoNoNoNo52812.053
813-Hexyloxacyclotridec-10-en-2-one18.52C18H30O2278.22401NoNoNoNo53691191.066
910-Octadecenoic acid,methyl ester18.82C19H36O2296.27101No NoNoNo 53644251.954
10Octadecanoic acid,methyl ester19.05C19H38O2298.28701No No No No 82010.956
11Dasycarpidan-1-methanol,acetate (ester)20.37C20H26N2O2326.4412NoNoNoNo5500720.543
12Aspidospermidine-3-carboxylic acid, 2,3-didehydro-,methyl ester,[5a,12a,19a]-20.65C21H26N2O2338.19913NoNoNoNo-2.123
13Cephalotaxine, 3-deoxy-3,11-epoxy-, (3a,11a)-22.96C18H19NO4313.13105NoNoNoNo-2.666
144-H-1-Benzopyran-4-one, 7-(acetyloxy)-2-(4-(acetyloxy)phenyl)-5-methoxy-25.6C19H14O7354.07315YesNo No Yes-2.456
Table
Table 2. In vitro free radical scavenging activity of AIRME. The results were compared with ascorbic acid and values represented as mean ± SD (n = 3).
Table 2. In vitro free radical scavenging activity of AIRME. The results were compared with ascorbic acid and values represented as mean ± SD (n = 3).
Conc. (µg/mL)Scavenging of DPPH Radical (%)Scavenging of Hydroxyl Radical (%)Conc. (µg/mL)Inhibition of Hydrogen Peroxide (%)Inhibition of Lipid Peroxidation (%)
AIRMEAscorbic AcidAIRMEAscorbic AcidAIRMEAscorbic AcidAIRMEAscorbic Acid
1041.02 ± 0.5850.38 ± 0.4046.17 ± 0.7753.81 ± 0.852022.53 ± 1.4142.68 ± 0.7620.68 ± 1.7233.06 ± 2.85
2056.92 ± 1.1561.46 ± 0.6653.82 ± 1.1361.88 ± 1.194041.73 ± 0.7055.88 ± 1.1331.03 ± 2.9743.34 ± 2.65
3062.82 ± 0.5970.36 ± 0.9960.74 ± 1.6168.48 ± 0.866051.00 ± 1.1759.44 ± 0.8340.80 ± 2.1050.77 ± 1.98
4066.02 ± 0.8077.04 ± 1.2164.69 ± 1.3082.36 ± 1.048058.31 ± 1.0962.49 ± 0.8052.58 ± 1,8758.66 ± 2.10
5068.46 ± 0.7078.88 ± 1.6571.48 ± 0.6384.41 ± 1.6110063.20 ± 1.2068.85 ± 0.6857.75 ± 2.0665.25 ± 3.06
IC5015.855.7114.745.28IC5065.4033.3179.7059.45
Table
Table 3. Effect of AIRME on white blood cells (WBC) and platelets count, and changes in serum C-reactive protein (CRP) in rats. Values represented as mean ± SD (n = 6). $ denotes significant at p < 0.05 compared with normal control (NC). Results are significant at p < 0.05 (*) and p < 0.01 (**) compared with disease control (DC).
Table 3. Effect of AIRME on white blood cells (WBC) and platelets count, and changes in serum C-reactive protein (CRP) in rats. Values represented as mean ± SD (n = 6). $ denotes significant at p < 0.05 compared with normal control (NC). Results are significant at p < 0.05 (*) and p < 0.01 (**) compared with disease control (DC).
GroupsWBC (109/L)Platelets (109/L)CRP (ng/mL)
NC3.95 ± 2.06320 ± 4.9428.93 ± 2.95
DC14.48 ± 4.76 $1025 ± 8.67 $55.94 ± 4.86 $
AIRME4.02 ± 2.14343 ± 5.0730.32 ± 3.06
AIRME-L+C9.76 ± 2.75 *765 ± 6.06 *36.98 ± 3.24 *
AIRME-H+C4.89 ± 2.43 **366 ± 5.51 **31.84 ± 3.095 **
ST 4.37 ± 2.14 **337 ± 5.06 **30.94 ± 3.065 **
NC—normal control; DC—disease control (carrageenan); AIRME—Acalypha indica roots methanolic extract; AIRME-L+C—AIRME-low dose plus carrageenan; AIRME-H+C—AIRME-high dose plus carrageenan and ST—standard treatment (diclofenac).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sahukari, R.; Punabaka, J.; Bhasha, S.; Ganjikunta, V.S.; Kondeti Ramudu, S.; Kesireddy, S.R.; Ye, W.; Korivi, M. Phytochemical Profile, Free Radical Scavenging and Anti-Inflammatory Properties of Acalypha Indica Root Extract: Evidence from In Vitro and In Vivo Studies. Molecules 2021, 26, 6251. https://doi.org/10.3390/molecules26206251

AMA Style

Sahukari R, Punabaka J, Bhasha S, Ganjikunta VS, Kondeti Ramudu S, Kesireddy SR, Ye W, Korivi M. Phytochemical Profile, Free Radical Scavenging and Anti-Inflammatory Properties of Acalypha Indica Root Extract: Evidence from In Vitro and In Vivo Studies. Molecules. 2021; 26(20):6251. https://doi.org/10.3390/molecules26206251

Chicago/Turabian Style

Sahukari, Ravi, Jyothi Punabaka, Shanmugam Bhasha, Venkata Subbaiah Ganjikunta, Shanmugam Kondeti Ramudu, Sathyavelu Reddy Kesireddy, Weibing Ye, and Mallikarjuna Korivi. 2021. "Phytochemical Profile, Free Radical Scavenging and Anti-Inflammatory Properties of Acalypha Indica Root Extract: Evidence from In Vitro and In Vivo Studies" Molecules 26, no. 20: 6251. https://doi.org/10.3390/molecules26206251

APA Style

Sahukari, R., Punabaka, J., Bhasha, S., Ganjikunta, V. S., Kondeti Ramudu, S., Kesireddy, S. R., Ye, W., & Korivi, M. (2021). Phytochemical Profile, Free Radical Scavenging and Anti-Inflammatory Properties of Acalypha Indica Root Extract: Evidence from In Vitro and In Vivo Studies. Molecules, 26(20), 6251. https://doi.org/10.3390/molecules26206251

Article Metrics

Back to TopTop